Medicare Enrolled
Dr. Dianne Petrone, M.D.
Rheumatology · Dallas, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Petrone from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Petrone?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Petrone
Dr. Dianne Petrone is a rheumatology specialist in Dallas, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Petrone performed 4,888 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Petrone received a total of $507,934 from 53 pharmaceutical and/or device companies across 2151 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Petrone is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 43% volume in TX
$507,934 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗4,888
Medicare services
Top 43% in TX for rheumatology
Not available
Unique patients (not deduplicated)
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,860 | $18 | $23 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
568 | $85 | $131 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
430 | $10 | $14 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
419 | $4 | $5 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
386 | $7 | $10 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
334 | $5 | $7 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
192 | $3 | $4 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
75 | $23 | $29 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
73 | $29 | $30 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
61 | $105 | $136 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
44 | $6 | $6 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
41 | $16 | $17 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
39 | $2 | $2 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
33 | $58 | $79 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
31 | $15 | $16 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
30 | $14 | $16 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
28 | $38 | $52 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
25 | $13 | $14 |
| Iron level test | 23 | $6 | $6 |
| Thyroxine (T4) level test A blood test that measures the total amount of thyroxine, a thyroid hormone, in your body. |
23 | $7 | $7 |
| Thyroid hormone evaluation A blood test to measure the levels of thyroid hormones in the body. This evaluation helps assess how well the thyroid gland is functioning. |
23 | $6 | $6 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
22 | $9 | $9 |
| New patient office visit, complex (60-74 min) | 21 | $174 | $222 |
| Trabecular bone score calculation This procedure calculates the trabecular bone score using imaging data to assess bone microarchitecture. It includes interpretation and a report on fracture risk. |
18 | $32 | $41 |
| Complement and antigen measurement A laboratory test to measure levels of complement proteins and antigens in the blood. |
17 | $12 | $12 |
| Complement function test A blood test that measures the activity of complement proteins, which are part of the immune system. |
17 | $12 | $12 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $59 | $92 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
14 | $3 | $3 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
13 | $6 | $7 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
11 | $15 | $19 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.2% high complexity
40.3% medium
58.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$507,934
Total received (2018-2024)
Avg $72,562/year across 7 years
Top 2% in TX for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
2,151
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$51,035
2023
$46,644
2022
$51,011
2021
$40,974
2020
$56,402
2019
$127,589
2018
$134,279
Payments by company (2024)
Janssen Biotech, Inc.
$29,610
GENZYME CORPORATION
$7,697
Novartis Pharmaceuticals Corporation
$3,452
Amgen Inc.
$3,416
UCB, Inc.
$2,093
E.R. Squibb & Sons, L.L.C.
$1,903
ABBVIE INC.
$512
Janssen Scientific Affairs, LLC
$430
AstraZeneca Pharmaceuticals LP
$291
PFIZER INC.
$250
GlaxoSmithKline, LLC.
$178
Lilly USA, LLC
$161
Fresenius Kabi USA, LLC
$157
Johnson & Johnson Health Care Systems Inc.
$150
ANI Pharmaceuticals, Inc.
$146
Boehringer Ingelheim Pharmaceuticals, Inc.
$133
SANOFI-AVENTIS U.S. LLC
$99
Janssen Research & Development, LLC
$82
Mallinckrodt Hospital Products Inc.
$79
Radius Health, Inc.
$65
Kiniksa Pharmaceuticals International, plc
$42
Organon Llc
$31
Alexion Pharmaceuticals, Inc.
$22
HOSPIRA, INC.
$21
DePuy Synthes Sales Inc.
$17
Top 3 companies account for 79.9% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Scientific Affairs, LLC
$80,935
Janssen Biotech, Inc.
$66,374
Lilly USA, LLC
$64,472
AbbVie, Inc.
$60,356
Novartis Pharmaceuticals Corporation
$53,584
Amgen Inc.
$52,079
E.R. Squibb & Sons, L.L.C.
$35,342
ABBVIE INC.
$27,539
AbbVie Inc.
$20,969
GENZYME CORPORATION
$16,584
Horizon Therapeutics plc
$9,735
UCB, Inc.
$4,931
Celgene Corporation
$2,745
NOVARTIS PHARMACEUTICALS CORPORATION
$2,670
Gilead Sciences, Inc.
$1,350
PFIZER INC.
$1,261
AstraZeneca Pharmaceuticals LP
$1,120
Aurinia Pharma U.S., Inc.
$851
GlaxoSmithKline, LLC.
$686
Mallinckrodt Hospital Products Inc.
$408
SANOFI-AVENTIS U.S. LLC
$395
Alexion Pharmaceuticals, Inc.
$358
Mallinckrodt Enterprises LLC
$339
Boehringer Ingelheim Pharmaceuticals, Inc.
$331
ANI Pharmaceuticals, Inc.
$300
Regeneron Healthcare Solutions, Inc.
$300
Mallinckrodt LLC
$264
Genentech USA, Inc.
$224
Fresenius Kabi USA, LLC
$201
Radius Health, Inc.
$175
Johnson & Johnson Health Care Systems Inc.
$150
Organon LLC
$93
Janssen Research & Development, LLC
$82
Antares Pharma, Inc.
$72
Horizon Pharma plc
$53
DePuy Synthes Sales Inc.
$53
Pacira Therapeutics, Inc.
$52
MEDEXUS PHARMA, INC.
$50
Ferring Pharmaceuticals Inc.
$46
Kiniksa Pharmaceuticals International, plc
$42
Bioventus LLC
$42
Hikma Pharmaceuticals USA
$40
MEDAC PHARMA, INC.
$38
Takeda Pharmaceuticals U.S.A., Inc.
$37
Merck Sharp & Dohme Corporation
$33
Organon Llc
$31
Celltrion USA Inc.
$28
Exeltis, USA Inc.
$28
HOSPIRA, INC.
$21
TerSera Therapeutics LLC
$19
Flexion Therapeutics, Inc.
$18
SOBI, INC
$16
Ironwood Pharmaceuticals, Inc
$13
Top 3 companies account for 41.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AMJEVITA · AVSOLA · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · Cimzia · Durolane · EUFLEXXA · EVENITY · Enbrel · FORTEO · HUMIRA · HYQVIA · Humira · IDACIO · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · Kineret · LINZESS · LUPKYNIS · LYRICA · MONOVISC · Mitigare · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · ORENCIA · ORTHOVISC · OTREXUP · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · Quzyttir · RAYOS · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SHINGRIX · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · SYNVISC-ONE · Sotyktu · Strensiq · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · ULTOMIRIS · Ultomiris · VPRIV · XELJANZ · YUFLYMA · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
95
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Petrone is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Petrone experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Petrone performed 1,860 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Petrone receive payments from pharmaceutical companies?
Yes. Dr. Petrone received a total of $507,934 from 53 companies across 2,151 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Petrone's costs compare to other rheumatologists in Dallas?
Dr. Petrone's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Petrone) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Dallas
Browse rheumatologists in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in TX
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in TX
Which TX rheumatologists receive the most from drug and device companies.
By company
Janssen Scientific Affairs, LLC Payments to Doctors
See all physicians who received payments from Janssen Scientific Affairs, LLC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology